Phoenix Biotech Acquisition Corp. (PBAXW) Financials

NASDAQ Currency in USD Disclaimer

$0.01

Last update: 01:52 PM EST
Day's range
$0.01
Day's range
$0.01
$0$0-$2M-$2M-$4M-$4M-$6M-$6M-$8M-$8M-$10M-$10M-$12M-$12MEarning2021202120222022202420246%6%5%5%4%4%3%3%2%2%1%1%0%0%Profit Margin
Profit Margin
Revenue
Earnings

PBAXW Income statement / Annual

Last year (2024), Phoenix Biotech Acquisition Corp.'s total revenue was $0.00, and the percentage change from the previous year is not available. In 2024, Phoenix Biotech Acquisition Corp.'s net income was -$11.09 M. See Phoenix Biotech Acquisition Corp.,s key income statements, including revenue, expenses, profit, and income.

Period FY-2024 FY-2022 FY-2021
Period Ended 12/31/2024 12/31/2022 12/31/2021
Operating Revenue $0.00 $0.00 $0.00
Cost of Revenue $0.00 $0.00 $0.00
Gross Profit $0.00 $254.83 K $0.00
Gross Profit Ratio 0 0 0
Research and Development Expenses $7.08 M $0.00 $0.00
General & Administrative Expenses $9.12 M $2.84 M $431.50
Selling & Marketing Expenses $0.00 $0.00 $251.27 K
Selling, General & Administrative Expenses $9.12 M $2.84 M $251.71 K
Other Expenses $0.00 $64.05 K -$80.32 K
Operating Expenses $16.20 M $2.91 M $332.03 K
Cost And Expenses $0.00 $2.91 M $332.03 K
Interest Income $0.00 $2.84 M $0.00
Interest Expense $0.00 $0.00 $0.00
Depreciation & Amortization $0.00 -$5.67 M $236.56 K
EBITDA -$16.20 M -$5.74 M -$332.03 K
EBITDA Ratio 0 0 0
Operating Income Ratio 0 0 0
Total Other Income/Expenses Net $5.11 M $2.84 K -$385.00
Income Before Tax -$11.09 M -$68.58 K -$332.42 K
Income Before Tax Ratio 0 0 0
Income Tax Expense $0.00 $599.16 K -$16.87 K
Net Income -$11.09 M -$667.74 K -$315.55 K
Net Income Ratio 0 0 0
EPS -0.22 -0.0099 -0.0046
EPS Diluted -0.22 -0.0099 -0.0046
Weighted Average Shares Out $49.68 M $67.48 M $68.94 M
Weighted Average Shares Out Diluted $49.68 M $67.48 M $68.94 M
Link